Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(5)
MIXED(5)
OTHER(5)
DEVICE(2)
Insulin (Humulin® R U-100)
2 trials
phase_2phase_2_3
wake-forest-university-health-sciences, university-of-southern-california
High Diet
1 trial
not_applicable
wake-forest-university-health-sciences
Low Diet
1 trial
not_applicable
wake-forest-university-health-sciences
20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
1 trial
phase_2
wake-forest-university-health-sciences
Insulin
1 trial
phase_2
wake-forest-university-health-sciences
40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
1 trial
phase_2
wake-forest-university-health-sciences
[11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan
1 trial
not_applicable
wake-forest-university-health-sciences
Saline
1 trial
phase_2
wake-forest-university-health-sciences

+8 more interventions

16 unique interventions4 categories

Analytics

Trial Phases

Phase 11
Phase 25
Phase 31

Trial Status

Completed9
Other2

Role Distribution

Principal Investigator10
Other Roles1
PI Rate91%

Activity Timeline

Clinical Trials (11)

NCT04199767Phase 2Completed
SNIFF Multi-Device Study 2
Cognitive ImpairmentMild Cognitive Impairment
PrincipalinvestigatorStart date: 2020-07-16
NCT03857321Phase 2Completed
Study of Nasal Insulin to Fight Forgetfulness - Device Study
Cognitive ImpairmentMild Cognitive Impairment
PrincipalinvestigatorStart date: 2019-04-12
NCT03472664Not ApplicableCompleted
Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
Alzheimer DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2018-07-16
NCT03130036Not ApplicableCompleted
Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease
Mild Cognitive Impairment
PrincipalinvestigatorStart date: 2015-06-09
NCT02462161Phase 1Completed
Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart
Alzheimer's DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2015-03-20
NCT03089827Enrolling By Invitation
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
Alzheimer DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2014-05-21
NCT01767909Phase 2/3Completed
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
StudydirectorStart date: 2014-01-08
NCT01595646Phase 2Completed
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
Alzheimer's DiseaseMild Cognitive Impairment
PrincipalinvestigatorStart date: 2011-11-01
NCT02463084Not ApplicableCompleted
Macronutrient Effects on Alzheimer's Disease (MEAL-2)
Insulin ResistanceMiddle AgeMild Cognitive Impairment+2 more
Principalinvestigator
NCT02984540Not ApplicableCompleted
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Insulin ResistanceMild Cognitive Impairment
Principalinvestigator

Showing 10 of 11 trials

Research Network

Collaboration Network

9 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Aisen, MD

USC Alzheimer's Therapeutic Research Institute (ATRI)

Moderately Similar
6 trials

Shared therapeutic areas:

Alzheimer DiseaseMild Cognitive ImpairmentAmnestic Mild Cognitive Impairment

Worked with same sponsors:

Alzheimer's Therapeutic Research InstituteNational Institute on Aging (NIA)+2 more
Collaborated on 1 trial
Similarity Score34%

Olivier Beauchet, MD

Jewish General Hospital

Related
19 trials

Shared therapeutic areas:

Alzheimer DiseaseCognitive Dysfunction
Similarity Score7%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Alzheimer DiseaseAlzheimer Disease, Early Onset
Similarity Score7%

Aruba Saeed, phd

Riphah International University

Related
19 trials

Shared therapeutic areas:

Cognitive DysfunctionMild Cognitive Impairment
Similarity Score7%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

Prediabetic StateCognitive Dysfunction
Similarity Score7%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

Insulin ResistancePrediabetic State
Similarity Score7%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Alzheimer DiseaseMild Cognitive Impairment
Similarity Score7%

Syed Shakil ur Rehman, PhD

Riphah International University

Related
17 trials

Shared therapeutic areas:

PrehypertensionPrediabetic State
Similarity Score7%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Alzheimer DiseaseMild Cognitive Impairment
Similarity Score7%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Prediabetic State
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT04199767Phase 2PrincipalInvestigator

SNIFF Multi-Device Study 2

Cognitive ImpairmentMild Cognitive Impairment
Completed
NCT03857321Phase 2PrincipalInvestigator

Study of Nasal Insulin to Fight Forgetfulness - Device Study

Cognitive ImpairmentMild Cognitive Impairment
Completed
NCT03472664Not ApplicablePrincipalInvestigator

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

Alzheimer DiseaseMild Cognitive Impairment
Completed
NCT03130036Not ApplicablePrincipalInvestigator

Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease

Mild Cognitive Impairment
Completed
NCT02462161Phase 1PrincipalInvestigator

Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart

Alzheimer's DiseaseMild Cognitive Impairment
Completed
NCT03089827PrincipalInvestigator

Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease

Alzheimer DiseaseMild Cognitive Impairment
Enrolling By Invitation
NCT01767909Phase 2/3StudyDirector

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Completed
NCT01595646Phase 2PrincipalInvestigator

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)

Alzheimer's DiseaseMild Cognitive Impairment
Completed
NCT02463084Not ApplicablePrincipalInvestigator

Macronutrient Effects on Alzheimer's Disease (MEAL-2)

Insulin ResistanceMiddle AgeMild Cognitive Impairment+2 more
Completed
NCT02984540Not ApplicablePrincipalInvestigator

Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease

Insulin ResistanceMild Cognitive Impairment
Completed
NCT05006599Phase 2PrincipalInvestigator

SNIFF - 3-Week Aptar CPS Device

Alzheimer Disease, Early OnsetCognitive ImpairmentMild Cognitive Impairment
Withdrawn

All 11 trials loaded